Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Shocking period pain away? new trial tests nerve zap for cramps

NCT ID NCT07307222

First seen Dec 29, 2025 · Last updated Jun 23, 2026 · Updated 22 times

Summary

This study tests whether a device that sends mild electrical pulses to a nerve in the ankle (TTNS) can reduce pain and distress from period cramps. Thirty-six women with primary dysmenorrhea will receive either standard care (heat packs and stretches) or standard care plus TTNS for 12 weeks. Researchers will measure pain intensity, menstrual symptoms, and quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY DYSMENORRHEA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

Locations

  • Damas Central Hospital

    Al Mansurah, Egypt

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

Transcutaneous Tibial Nerve Stimulation (TTNS) device

What this could lead to

If it works, this could offer a drug-free option to reduce menstrual pain and distress.

What could go wrong

This is a small, early-stage trial with only 36 participants, so results may not apply to everyone. The treatment is non-invasive but may not work for all.

Conditions

The condition(s) this trial relates to.

primary dysmenorrhea

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.